Privia Health (PRVA) Insider Shawn Buys $126K of Stock
Insider Morris Matthew Shawn purchased an additional 63,212 shares of Privia Health Group, valued at $126,424.
Reviewed by automated data checks against the source filing. How we make and check alerts
Morris Matthew Shawn bought 63,212 shares of Privia Health Group, Inc. ($PRVA) at an average price of $2, worth about $126,424, on June 29, 2026. The trade was reported to the SEC in a Form 4 filing.
Since the trade, $PRVA is up 6.4% after 1 week, down 5.6% after 1 month and down 11.9% to date (from the $25.55 close on Jun 29, 2026).
PRVA
Privia Health Group, Inc.
Key Points
- Morris Matthew Shawn bought 63,212 shares of Privia Health Group (PRVA) for a total of $126,424 on June 29, 2026.
- This latest purchase follows a previous buy of 88,110 shares at $2 each on June 26, 2026.
- Privia Health operates in the healthcare sector and is valued at approximately $2.50 billion.
Get $PRVA trade alerts by text
We text you when insiders, Congress or big funds trade $PRVA. Free.
Not investment advice. EarningsIQ is not a registered investment adviser, and this automated Privia Health Group, Inc. alert may contain errors. Disclosures
Matthew Shawn Expands His Investment
Morris Matthew Shawn bought 63,212 shares of Privia Health Group, Inc. (PRVA) for about $126,424. This transaction took place on June 29, 2026. His latest buy came after he had purchased 88,110 shares at $2.00 each just days earlier on June 26, 2026.
Insider Buying and Selling at Privia Health Group, Inc.
In addition to Matthew Shawn's recent buy, he had already purchased 88,110 shares on June 26, 2026, for a total value of $176,220. Another insider, David Mountcastle, the Chief Financial Officer, sold 17,196 shares on the same day for about $432,995 as part of a planned transaction.
How Privia Health Group, Inc. Stock Has Traded
Shares of PRVA closed at $25.73 on the day of Matthew Shawn's latest purchase, which is significantly higher than the previous close of $19.85. The stock is within its 52-week range of $19.42 to $28.82, suggesting it has seen some volatility recently.
Company Background
Privia Health Group operates as a national physician-enablement company, focusing on collaborating with healthcare providers to enhance patient care. This strategic buy by an insider may signal confidence in the company's direction, especially in a growing healthcare market.
What’s Next for Privia Health
Investors should keep an eye on upcoming earnings on November 5, 2026, to see how the company continues to perform. As a reminder, insider trades, including Shawn's recent purchases, reflect past transactions and may not indicate current market conditions.
Related Filing Alerts
Source: Morris Matthew Shawn's Form 4 filing on $PRVA (Jun 29, 2026). Find the original filing: PRVA Form 4 filings on SEC EDGAR. Written by software, not financial advice. How we make alerts